Notify me when Sage Rhino Capital Llc files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| VINC | Vincerx Pharma, Inc. | Common Stock | 0% | $426 | 4.26K | Sage Rhino Capital, LLC | 29 Jan 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|